Follow
Carlos Francisco Madrazo-Moya
Carlos Francisco Madrazo-Moya
Instituto de Biomedicna de Valencia
Verified email at alumni.uv.es
Title
Cited by
Cited by
Year
Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico
CF Madrazo-Moya, I Cancino-Muñoz, B Cuevas-Cordoba, ...
PLoS One 14 (6), e0213046, 2019
192019
Whole genomic sequencing based genotyping reveals a specific X3 sublineage restricted to Mexico and related with multidrug resistance
AC Jiménez-Ruano, CF Madrazo-Moya, I Cancino-Muñoz, ...
Scientific Reports 11 (1), 1870, 2021
72021
Characterization of polymorphisms associated with multidrug-resistant tuberculosis by whole genomic sequencing: a preliminary report from Mexico
R Zenteno-Cuevas, E Fernandez, D Viveros, CF Madrazo-Moya, ...
Microbial Drug Resistance 26 (7), 732-740, 2020
32020
Fine-grain population structure and transmission patterns of Mycobacterium tuberculosis in southern Mozambique, a high TB/HIV burden area
B Saavedra Cervera, MG López, Á Chiner-Oms, AM García, ...
Microbial Genomics 8 (7), 000844, 2022
12022
Whole genome sequencing, a novel and powerful tool against tuberculosis
CF Madrazo-Moya, R Zenteno-Cuevas
J Public Heal Emerg 1, 2017
12017
Whole genome sequencing analysis to evaluate the influence of T2DM on polymorphisms associated with drug resistance in M. tuberculosis
GA Bermudez-Hernández, DE Pérez-Martínez, CF Madrazo-Moya, ...
BMC genomics 23 (1), 1-9, 2022
2022
SNPs in Genes Related to DNA Damage Repair in Mycobacterium Tuberculosis: Their Association with Type 2 Diabetes Mellitus and Drug Resistance
DE Pérez-Martínez, GA Bermúdez-Hernández, CF Madrazo-Moya, ...
Genes 13 (4), 609, 2022
2022
Secuenciación del genoma como herramienta para el diagnóstico de tuberculosis farmacorresistente circulante en Veracruz, México
CF Madrazo Moya
Universidad Veracruzana. Faculta de Ciencias de la Salud. Región Xalapa, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–8